Last updated on August 4, 2026 · Originally published January 26, 2017
There is a good chance you are within arm’s reach of some linalool right now. It is used in an estimated 60 to 80% of cosmetic and personal-care products, and turns up widely in household fragrances too — the shampoo, the laundry detergent, the dish soap.
It is also the compound most people mean when they say lavender smells calming. That reputation has followed linalool into cannabis, where it is the terpene most reliably described as relaxing. Whether it has earned the description turns out to be a more interesting question than it looks.
Linalool is an acyclic monoterpene alcohol with the formula C₁₀H₁₈O. It occurs in two mirror-image forms, or enantiomers, whose proportions vary between plants and whose odors are perceptibly different from one another. Lavender is its most familiar source, but it also occurs in coriander, basil, rosewood, mint, some cinnamon species, and even certain fungi — more than 200 plant species produce it.
The odor is more complicated than “floral” suggests. There is spice in it, and wood, and a thread of citrus. It is also used as a food additive to enhance flavor.
Molecular mass: 154.25 g/mol Boiling point: approximately 198 °C (388 °F)
The calm reputation, and where it comes from
Linalool is widely used in aromatherapy products marketed for stress and agitation, which is why it turns up in so many candles, massage oils and beauty products.
That reputation is not invented. It rests on a real body of research — but the research is mostly about lavender, and the distinction matters more than it first appears.
Human studies reporting anxiolytic effects have generally tested lavender essential oil preparations, not isolated linalool. Lavender oil is a mixture, and its two dominant components are linalool and linalyl acetate, an ester derived from linalool. A trial of lavender oil is a trial of that combination in its natural proportions, plus whatever else the distillation carried over. It is evidence that lavender oil does something. It is not evidence that linalool did it.
Animal research is more direct, because some experiments have tested the compound itself. It is also much harder to translate. In a frequently cited 2002 study, linalool and linalyl acetate each reduced experimentally induced paw edema in rodents at doses measured in tens of milligrams per kilogram. That establishes biological activity under those conditions. It does not establish that inhaling the trace amount present in cannabis does anything comparable.
The dose problem
Here is the part that rarely gets said, and it is why a lavender study cannot simply be read across to a jar of flower.
The amounts do not correspond. A 2025 randomized crossover trial enrolled 125 people with insomnia and tested 300 mg of CBD combined with 1 mg each of eight terpenes, linalool among them. Among the 56 participants included in the sleep-stage analysis, the formulation increased combined slow-wave and REM sleep by 1.3 percentage points against placebo — statistically significant, but small. Under the adjusted analysis, the absolute number of minutes gained did not reach significance, and total sleep time did not improve.
Even taken at face value, the trial cannot tell you what the linalool contributed. It was one of nine active ingredients, present at one three-hundredth of the CBD dose. The study was also funded by Defined Research, Inc., and several authors reported holding equity in the company whose formulation was being tested. That does not invalidate the result, but a proprietary product evaluated by people with a financial interest in it deserves the label.
Cannabis itself carries linalool at fractions of a percent of dry weight. So “linalool is calming” can be entirely true of a lavender oil capsule and still tell you very little about what a cultivar high in linalool will do.
What the entourage research found
If linalool works in cannabis, the obvious mechanism would be modifying how cannabinoids behave. That specific version of the idea has been tested directly, and the results were negative.
Work examining whether common cannabis terpenoids alter the activity of THC at the human CB1 and CB2 receptors found no such modulation, linalool included — the paper was published under the title Absence of Entourage. A companion study looking at TRPA1 and TRPV1 channels reached the same conclusion. Neither result rules out an entourage effect by some other route, and later work has reported terpenes acting directly at cannabinoid receptors rather than through THC. But the simplest version of the story, in which linalool amplifies THC at the receptor, did not survive testing.
What has tested linalool on its own and found something is pain research. A 2025 study gave four cannabis terpenes to mice in post-operative and fibromyalgia pain models. Geraniol produced the strongest effect, with linalool and α-humulene next, and blocking the adenosine A2A receptor blocked the response — pointing to a mechanism with nothing to do with cannabinoid receptors at all. That is mice, at 200 mg/kg by injection, so it says nothing direct about people. It remains one of the clearest recent demonstrations that linalool can produce an effect in its own right.
What happens as it ages
There is a wrinkle here that the aromatherapy framing misses completely.
Linalool itself appears to be a weak sensitizer at most. The greater problem begins after air exposure, when it autoxidizes into a mixture containing linalool hydroperoxides — substances capable of producing allergic contact dermatitis in people who have become sensitized to them.
This is not a marginal concern. A ten-year registry study of 6,719 consecutively patch-tested patients in Denmark found 3.1% reacting positively to linalool hydroperoxides, and series in the US and UK have reported higher rates depending on population and test concentration. Those figures describe a dermatology patch-test population rather than the public at large, but they establish oxidized linalool as one of the more common fragrance allergens in clinical practice.
There is a commercial consequence to the same instability. Like other volatile monoterpenes, linalool can be lost during drying, heating, decarboxylation and some extraction processes, though how much survives depends heavily on the method. Manufacturers sometimes add it back afterward, often sourced from lavender rather than cannabis. Linalool has the same chemical identity regardless of its botanical source, though the balance of its two enantiomers and the compounds accompanying it may differ. What also changes is the provenance, and whether the finished profile still represents the plant it came from.
Linalool in cannabis
Linalool appears on certificates of analysis for cultivars sold under names like Lavender, Pink Kush and LA Confidential, but those names guarantee nothing about a particular batch. Testing tells you more than lineage folklore does.
Laboratory and animal studies have explored linalool in models of anxiety, depression, seizures, inflammation, pain and psychosis. The breadth of that list is less impressive than it sounds. Most of the evidence remains preclinical, much of it uses doses far above anything cannabis delivers, and little has been confirmed in rigorous human trials. A 2021 review of pinene and linalool as candidate brain-health medicines reached that conclusion explicitly: both compounds look promising across stroke, pain, cognition, insomnia, anxiety and depression, and the absence of well-designed clinical trials is the central gap.
Which is roughly where linalool sits. Better studied than most terpenes, more plausible than most, and still short of the evidence that would let anyone tell you what the linalool in your flower is doing. For the wider context, see our guide to cannabis terpenes — and for why the amount that survives processing is a question in itself, our article on decarboxylation.
Reviewed by Nani Frenkel, Chief Editor
Originally published January 26, 2017.Updated August 2, 2026. This article was substantially expanded from its 2017 original: New sections cover the distinction between lavender-oil and isolated-linalool evidence, the dose gap between clinical studies and cannabis exposure, the entourage null results, adenosine A2A antinociception, and contact allergy from oxidized linalool. The description of topical linalool safety has been corrected, and material has been incorporated from “The Monoterpene Alcohol Called Linalool” by Derek Johnson, published September 10, 2020.
Research for this article was compiled using DeepWeed, T&T’s cannabis research database — explore the underlying studies there.
Sources
- Sugawara Y, Hara C, Tamura K, et al. Odor distinctiveness between enantiomers of linalool. Chem Senses. 2000;25(1):77–84
- Zhang C, Chen X, Lee RTC, et al. Bioinformatics-aided identification, characterization and applications of mushroom linalool synthases. Commun Biol. 2021;4:223. doi:10.1038/s42003-021-01715-z
- Peana AT, D’Aquila PS, Panin F, Serra G, Pippia P, Moretti MD. Anti-inflammatory activity of linalool and linalyl acetate constituents of essential oils. Phytomedicine. 2002;9(8):721–726. doi:10.1078/094471102321621322
- Kamatou GPP, Viljoen AM. Linalool — a review of a biologically active compound of commercial importance. Nat Prod Commun. 2008;3(7):1183–1192
- Santiago M, Sachdev S, Arnold JC, McGregor IS, Connor M. Absence of entourage: terpenoids commonly found in Cannabis sativa do not modulate the functional activity of Δ9-THC at human CB1 and CB2 receptors. Cannabis Cannabinoid Res. 2019;4(3):165–176. doi:10.1089/can.2019.0016
- Heblinski M, Santiago M, Fletcher C, et al. Terpenoids commonly found in Cannabis sativa do not modulate the actions of phytocannabinoids or endocannabinoids on TRPA1 and TRPV1 channels. Cannabis Cannabinoid Res. 2020;5(4):305–317. doi:10.1089/can.2019.0099
- LaVigne JE, Hecksel R, Keresztes A, Streicher JM. Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity. Sci Rep. 2021;11:8232. doi:10.1038/s41598-021-87740-8
- Weston-Green K, Clunas H, Jimenez Naranjo C. A review of the potential use of pinene and linalool as terpene-based medicines for brain health. Front Psychiatry. 2021;12:583211. doi:10.3389/fpsyt.2021.583211
- Seekins CA, Welborn AM, Schwarz AM, Streicher JM. Select terpenes from Cannabis sativa are antinociceptive in mouse models of post-operative pain and fibromyalgia via adenosine A2A receptors. Pharmacol Rep. 2025;77(1):172–181. doi:10.1007/s43440-024-00687-1
- Wang M, Faust M, Abbott S, et al. Effects of a cannabidiol/terpene formulation on sleep in individuals with insomnia: a double-blind, placebo-controlled, randomized, crossover study. J Clin Sleep Med. 2025;21(1):69–80. doi:10.5664/jcsm.11324
- de Groot AC. Linalool hydroperoxides. Dermatitis. 2019;30(4):243–246
- Botvid SHC, et al. Ten years of patch testing to hydroperoxides of limonene and linalool: prevalence, patterns and clinical insights. Contact Dermatitis. 2026. doi:10.1111/cod.70102
